NO984290L - Pharmaceutically useful compounds - Google Patents

Pharmaceutically useful compounds

Info

Publication number
NO984290L
NO984290L NO984290A NO984290A NO984290L NO 984290 L NO984290 L NO 984290L NO 984290 A NO984290 A NO 984290A NO 984290 A NO984290 A NO 984290A NO 984290 L NO984290 L NO 984290L
Authority
NO
Norway
Prior art keywords
pharmaceutically useful
useful compounds
compounds
arylpyrazolisoquinoline
pharmaceuticals
Prior art date
Application number
NO984290A
Other languages
Norwegian (no)
Other versions
NO984290D0 (en
Inventor
John Bantick
Roger Bonnert
Peter Cage
David Donald
Mark Furber
Simon Hirst
Matthew Perry
Eifion Phillips
Original Assignee
Astra Pharma Prod
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605803.7A external-priority patent/GB9605803D0/en
Priority claimed from GBGB9610474.0A external-priority patent/GB9610474D0/en
Priority claimed from GBGB9610894.9A external-priority patent/GB9610894D0/en
Priority claimed from GBGB9700862.7A external-priority patent/GB9700862D0/en
Application filed by Astra Pharma Prod, Astra Ab filed Critical Astra Pharma Prod
Publication of NO984290D0 publication Critical patent/NO984290D0/en
Publication of NO984290L publication Critical patent/NO984290L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

2-arylpyrazolisokinolin- og -cinnolinonderivater, fremgangsmåter for deres fremstilling, deres anvendelse som legemidler, og farmasøytiske formuleringer inneholdende disse forbindelsene.2-arylpyrazolisoquinoline and quinolinone derivatives, processes for their preparation, their use as pharmaceuticals, and pharmaceutical formulations containing these compounds.

NO984290A 1996-03-20 1998-09-16 Pharmaceutically useful compounds NO984290L (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9605803.7A GB9605803D0 (en) 1996-03-20 1996-03-20 Pharmaceutically-active compound
GBGB9610474.0A GB9610474D0 (en) 1996-05-18 1996-05-18 Pharmaceutically active compounds
GBGB9610894.9A GB9610894D0 (en) 1996-05-24 1996-05-24 Pharmaceutically useful compounds
GBGB9700862.7A GB9700862D0 (en) 1997-01-16 1997-01-16 Pharmaceutically useful compounds
PCT/SE1997/000471 WO1997034893A1 (en) 1996-03-20 1997-03-20 Pharmaceutically useful compounds

Publications (2)

Publication Number Publication Date
NO984290D0 NO984290D0 (en) 1998-09-16
NO984290L true NO984290L (en) 1998-10-27

Family

ID=27451427

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984290A NO984290L (en) 1996-03-20 1998-09-16 Pharmaceutically useful compounds

Country Status (19)

Country Link
EP (1) EP0888347A1 (en)
JP (1) JP2000506884A (en)
KR (1) KR20000064716A (en)
CN (1) CN1218472A (en)
AR (1) AR006520A1 (en)
AU (1) AU712141B2 (en)
BR (1) BR9708103A (en)
CA (1) CA2247814A1 (en)
CZ (1) CZ297798A3 (en)
EE (1) EE9800298A (en)
ID (1) ID16283A (en)
IL (1) IL126271A0 (en)
IS (1) IS4848A (en)
NO (1) NO984290L (en)
NZ (1) NZ331614A (en)
PL (1) PL328921A1 (en)
SK (1) SK118798A3 (en)
TR (1) TR199801861T2 (en)
WO (1) WO1997034893A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110749A1 (en) * 2001-03-07 2002-09-12 Bayer Ag Substituted aminodicarboxylic acid derivatives
JP2003002863A (en) * 2001-06-25 2003-01-08 Nippon Soda Co Ltd Method for producing benzoic acids, and new compound
SE0102404D0 (en) * 2001-07-04 2001-07-04 Active Biotech Ab Novel immunomodulating compounds
US6642249B2 (en) 2001-07-04 2003-11-04 Active Biotech Ab Immunomodulating compounds
DE10229762A1 (en) * 2002-07-03 2004-01-22 Aventis Pharma Deutschland Gmbh Pyrazoloisoquinoline derivatives for the inhibition of NFkappaB-inducing kinase
JP2006509047A (en) * 2002-11-22 2006-03-16 アクティブ バイオテック アクチボラーグ Pyrazoloquinolines with immunomodulatory activity
US7674906B2 (en) 2002-12-16 2010-03-09 Active Biotech Ab Tetracyclic immunomodulatory compounds
DE602004030225D1 (en) 2003-03-14 2011-01-05 Medigene Ltd IMMUNOMODULATING HETEROCYCLIC COMPOUNDS
GB0325644D0 (en) 2003-11-04 2003-12-10 Avidex Ltd Immuno ihibitory pyrazolone compounds
KR20070001922A (en) 2003-12-12 2007-01-04 와이어쓰 Quinolines useful in treating cardiovascular disease
FR2870239B1 (en) * 2004-05-11 2006-06-16 Sanofi Synthelabo DERIVATIVES OF 2H- OR 3H-BENZO [E] INDAZOL-1-YLE CARBAMATE, THEIR PREPARATION AND THEIR THERAPEUTIC USE.
GB0411770D0 (en) * 2004-05-26 2004-06-30 Avidex Ltd Immuno inhibitory heterocyclic compouds
US7932253B2 (en) 2004-08-09 2011-04-26 Medigene Ag Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors
MY145795A (en) 2006-10-31 2012-04-30 Pfizer Prod Inc Pyrazoline compounds
CN102372710A (en) 2010-08-18 2012-03-14 山东轩竹医药科技有限公司 Fused cyclic compound being taken as mineral corticoid recept antagonist
AU2012215741A1 (en) 2011-02-09 2013-08-22 Nissan Chemical Industries, Ltd. Pyrazole derivative and pest control agent
ES2954572T3 (en) 2018-09-07 2023-11-23 Merck Patent Gmbh 5-morpholin-4-yl-pyrazolo[4,3-b]pyridine derivatives
WO2021257857A1 (en) 2020-06-19 2021-12-23 Incyte Corporation Naphthyridinone compounds as jak2 v617f inhibitors
WO2021257863A1 (en) 2020-06-19 2021-12-23 Incyte Corporation Pyrrolotriazine compounds as jak2 v617f inhibitors
KR20230057341A (en) 2020-07-02 2023-04-28 인사이트 코포레이션 Tricyclic urea compounds as JAK2 V617F inhibitors
WO2022006456A1 (en) 2020-07-02 2022-01-06 Incyte Corporation Tricyclic pyridone compounds as jak2 v617f inhibitors
US11661422B2 (en) 2020-08-27 2023-05-30 Incyte Corporation Tricyclic urea compounds as JAK2 V617F inhibitors
US11919908B2 (en) 2020-12-21 2024-03-05 Incyte Corporation Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
AR125273A1 (en) 2021-02-25 2023-07-05 Incyte Corp SPIROCYCLIC LACTAMS AS JAK2 INHIBITORS V617F

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524146A (en) * 1982-12-08 1985-06-18 Ciba-Geigy Corporation Certain -2-heterocycle substituted pyrazoloquinolines
JPS61112075A (en) * 1984-11-05 1986-05-30 Shionogi & Co Ltd Thienylpyrazoloquinoline derivative
SE8903564D0 (en) * 1989-10-26 1989-10-26 Pharmacia Ab NEW USE CONDENSED QUINOLINE COMPOUND
JPH05194515A (en) * 1991-07-31 1993-08-03 Kyowa Hakko Kogyo Co Ltd Condensed naphthyridine derivative

Also Published As

Publication number Publication date
JP2000506884A (en) 2000-06-06
EE9800298A (en) 1999-02-15
IS4848A (en) 1998-09-16
ID16283A (en) 1997-09-18
PL328921A1 (en) 1999-03-01
SK118798A3 (en) 1999-03-12
BR9708103A (en) 1999-07-27
AR006520A1 (en) 1999-09-08
CZ297798A3 (en) 1999-03-17
NO984290D0 (en) 1998-09-16
NZ331614A (en) 2000-07-28
IL126271A0 (en) 1999-05-09
EP0888347A1 (en) 1999-01-07
AU2186797A (en) 1997-10-10
AU712141B2 (en) 1999-10-28
TR199801861T2 (en) 1998-12-21
WO1997034893A1 (en) 1997-09-25
CN1218472A (en) 1999-06-02
CA2247814A1 (en) 1997-09-25
KR20000064716A (en) 2000-11-06

Similar Documents

Publication Publication Date Title
NO984290L (en) Pharmaceutically useful compounds
DK1202965T3 (en) Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medical use
NO964700D0 (en) Novel amino acid derivatives, processes for their preparation and pharmaceutical compositions containing these compounds
NO20001409L (en) Carboxamidothiazole derivatives, processes for their preparation and pharmaceutical compositions
NO20032733L (en) Diphenyllazetidinone derivatives, process for their preparation, drugs containing these compounds and their use
NO991815L (en) Oxadiazoles, processes for their preparation and their use as drugs
NO20015309L (en) 1- (P-thienylbenzyl) imidazoles as anginotensin (1-7) receptor agonists, process for the preparation and use of the same and pharmaceutical preparations containing said compounds
NO20002787L (en) New connections
DK0885204T3 (en) New arylglycinamide derivatives, processes for their preparation and pharmaceutical compositions containing these compounds
NO20016038L (en) Benzene derivatives, processes for their preparation and pharmaceutical compositions containing the same
NO994671D0 (en) Aryl- or heteroarylsulfonamide-substituted hydroxamic acid derivatives, processes for their preparation and their use as pharmaceuticals
NO994620D0 (en) New 2- (iminomethyl) amino-phenyl derivatives, preparation, use as medicines and pharmaceutical compositions containing them
NO980178L (en) Cyclooxygenase inhibitor and amidine derivative salts, process for their preparation, use thereof as drugs, and pharmaceutical compositions containing such derivatives
DK1117661T3 (en) Propanolamine derivatives substituted with heterocyclic groups, process for their preparation, pharmaceutical preparations containing these compounds and their use
NO974934D0 (en) 10,13,15-Trioxatricyclo [9.2.1.19.6] pentadecanone derivatives, process for their preparation and drugs containing these compounds
NO960272L (en) Oxathiolanes, processes for their preparation and pharmaceutical compositions containing the same
NO992998D0 (en) New analogues of camptotecin, use as drugs and pharmaceutical compositions containing them
NO930796D0 (en) GLYCOPEPTY DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THESE
NO20016404D0 (en) Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
DK1017681T3 (en) Hydrazone-benzazulin derivatives, pharmaceuticals and intermediates
NO20013878L (en) (1-Phenacy-3-phenyl-3-piperidylethyl) piperidine derivatives, process for their preparation and pharmaceutical preparations containing the same
NO20014632D0 (en) New morpholine derivatives, processes for their preparation and pharmaceutical preparations containing said derivatives
DK0858459T3 (en) New Acidic Pyrazole Compounds, Processes for their Preparation, Their Use as Drugs, Their New Use and Pharmaceutical Preparations Containing Them
NO933558D0 (en) BENZIMIDAZOLES, PHARMACEUTICALS CONTAINING THESE COMPOUNDS, AND PROCEDURE FOR THEIR PREPARATION
DK1157014T3 (en) Polycyclic 2-amino-dihydrothiazole systems, process for their preparation and their use as drugs